AIM-listed Mission Marketing Group has bought RJW & Partners, a provider of consultancy services to the pharmaceutical and medical devices industries, for up to £6.23m....
READ MORE
|
The pharmaceutical industry’s powerful Washington trade association fell in size by almost two dozen companies after revising membership rules amid the debate over U.S. drug prices....
READ MORE
|
Novartis is to buy US biotech IFM Tre in a deal worth up to $1.575 billion, adding a potential drug for the fatty liver disease known as NASH to its pipeline. IFM Tre is a subsidiary of cancer biotech IFM Therapeutics, which was bought by Bristol-Myers Squibb in 2017 in a deal worth $2.3 billion. At the time IFM’s non-oncology assets were spun out into two biotechs – IFM Tre and IFM Due, focusing on NLRP3 antagonists, and cGAS/STING antagonists respectively. The acquisition gives Nov...
PHARMAPHORUM
READ MORE
|
Allergan has confirmed it will hive off two drugs so that AbbVies 63 billion dollars takeover offer could pass U.S. antitrust scrutiny. But recent regulatory decision and indecision on pharma deals has analysts worried whether that would be enough. In an investor Q and A published Tuesday, Allergan said it will sell brazikumab and Zenpep as part of the merger process, “irrespective of whether such divestitures are required by the regulators.” Those two have been suspected for-sale ta...
READ MORE
|
Sophiris Bio has completed its investigation into the death of a patient that halted additional dosing in a trial of its lead candidate topsalysin two months ago, finding its procedure for localized prostate cancer was unlikely to be the cause. Sophiris’ stock was up 30% on the news, after dropping precipitously in June. The company said it has notified regulatory authorities in the U.S. and the U.K., where the open-label phase 2b study is being conducted. Topsalysin, a transmembrane, pore...
CONOR HALE
READ MORE
|
Researchers say that new 'mini-placentas'—a cellular model of the early stages of the placenta—could provide a window into early pregnancy and help transform our understanding of reproductive disorders. Details of this new research are published today in the journal Nature. Many pregnancies fail because the embryo does not implant correctly into the lining of the womb (uterus) and fails to form a placental attachment to the mother. Yet, because of the complexities of studying...
READ MORE
|